Comprehensive Guide to 2,4-Diamino-6-Piperidinopyrimidine
Table of Contents
- 1. Product Overview & Specifications
- 2. Key Applications & Industrial Uses
- 3. Comparative Analysis with Analogues
- 4. Usage Guidelines & Best Practices
- 5. Industry Case Studies
- 6. Procurement Support
1. Product Overview & Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | 2,4-Diamino-6-piperidinopyrimidine |
| CAS Number | 1032358-38-7 |
| Molecular Formula | C9H14N6 |
| Purity Grade | ≥98% (HPLC) |
| Storage Conditions | 2-8°C in inert atmosphere |
2. Key Applications & Industrial Uses
Pharmaceutical Intermediates
Critical component in kinase inhibitor development for oncology treatments
Chemical Synthesis
Building block for heterocyclic compound synthesis in medicinal chemistry
Research Applications
Used in structure-activity relationship (SAR) studies for drug discovery
3. Comparative Analysis with Analogues
| Compound | Solubility | Stability | Reactivity |
|---|---|---|---|
| 2,4-Diamino-6-piperidinopyrimidine | Soluble in DMSO, DMF | Stable up to 6 months | High nucleophilic reactivity |
| 2-Aminopyrimidine | Partial solubility | 3-month stability | Moderate reactivity |
4. Usage Guidelines & Best Practices
Handling Procedures
Always use anhydrous conditions for sensitive reactions
Reaction Optimization
Recommended catalyst: Pd(PPh3)4 for cross-coupling reactions
5. Industry Case Studies
Case 1: Oncology Drug Development
XYZ Pharma achieved 40% yield improvement in CDK inhibitor synthesis through optimized purification protocols
Case 2: Antiviral Research
ABC Labs utilized this compound to develop novel RSV inhibitors with IC50 values ≤50nM
Case 3: Agricultural Chemistry
AgroChem Co. created next-gen fungicides using derivative compounds
6. Procurement Support
Contact our technical team for:
- Custom synthesis options
- Bulk pricing (100kg+ quantities)
- Regulatory documentation support
Email: info@vivalr.com
Phone: (86) 15866781826
Request detailed technical dossier or schedule lab demonstration:
[Contact Form Integration Point]


评论
目前还没有评论。